Arovella Therapeutics Limited Financial Overview
Arovella Therapeutics Limited's market cap is currently AU$106.68M. The company's EPS TTM is AU$-0.006; its P/E ratio is -13.09; Arovella Therapeutics Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
